Tyro Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HNGE
Hinge Health
HNGE
|
+$16.7M |
| 2 |
Cogent Communications
CCOI
|
+$12.5M |
| 3 |
Carpenter Technology
CRS
|
+$12.4M |
| 4 |
Crocs
CROX
|
+$9.95M |
| 5 |
LENZ
LENZ Therapeutics
LENZ
|
+$3.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNA
Verona Pharma
VRNA
|
+$20.3M |
| 2 |
Liquidia Corp
LQDA
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.97% |
| 2 | Communication Services | 22.79% |
| 3 | Industrials | 19.28% |
| 4 | Consumer Discretionary | 17.91% |
| 5 | Materials | 16.06% |
Similar funds
Tyro Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Tyro Capital Management held 12 positions worth $269M, up 5.6% from $255M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tyro Capital Management deployed $27.2M of net new capital in Q3 2025, opening 2 new positions and adding to 8 existing holdings. Its largest new stake was Hinge Health: 319,076 shares worth $15.7M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 32% a quarter earlier, followed by Communication Services and Industrials.
On the sell side, the most notable exit was Verona Pharma, an estimated $20.3M sold.
- Tyro Capital Management's largest Q3 2025 buy was Hinge Health: 319,076 shares worth $15.7M.
- Tyro Capital Management added most to Cogent Communications in Q3 2025, an estimated $12.5M increase.
- Tyro Capital Management fully exited Verona Pharma in Q3 2025, selling an estimated $20.3M.
- Tyro Capital Management's ten largest holdings make up 100% of its $269M portfolio in Q3 2025.
- Tyro Capital Management opened 2 new positions and closed 2 in Q3 2025.
- Tyro Capital Management's portfolio value rose 5.6% quarter-over-quarter to $269M.
Based on Tyro Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.